-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Valomaciclovir stearate
![{PARAM:[Name]}({[CAS]})](https://resource.bocsci.com/structure/195156-77-52d.gif)
| Category | Herpes simplex Virus (HSV) |
| CAS | 195156-77-5 |
| Description | Valomaciclovir stearate is a DNA polymerase inhibitor that acts as the prodrug of omaciclovir. Valomaciclovir stearate has developed for the treatment of Herpes Zoster. |
Product Information
| Synonyms | Valomaciclovir stearate;195156-77-5;ABT-606;MIV 606;Valomaciclovir stearate [USAN];506LI1B3A3;A-174606.0;[(2R)-4-[(2S)-2-amino-3-methylbutanoyl]oxy-2-[(2-amino-6-oxo-3H-purin-9-yl)methyl]butyl] octadecanoate;Valomaciclovir stearate (USAN);L-Valine, 4-ester with 9-((R)-4-hydroxy-2-(hydroxymethyl)butyl)guanine, stearate (ester);(R)-4-(((S)-2-Amino-3-methylbutanoyl)oxy)-2-((2-amino-6-oxo-1H-purin-9(6H)-yl)methyl)butyl stearate;[(2R)-4-[(2S)-2-amino-3-methylbutanoyl]oxy-2-[(2-amino-6-oxo-1H-purin-9-yl)methyl]butyl] octadecanoate;L-Valine, (3R)-3-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methyl)-4-((1-oxooctadecyl)oxy)butyl ester;UNII-506LI1B3A3;ABT 606;EPB 348;A 174606.0;SCHEMBL709408;CHEMBL2105845;DTXSID00173167;ACBSZTQIFTYFGH-IAPPQJPRSA-N;AKOS040749739;VALOMACICLOVIR STEARATE [WHO-DD];DA-58952;HY-19288;CS-0015028;D06275;Q27260763;(R)-9-[2-(Stearoyloxymethyl)-4-(L-valyloxy)butyl]guanine;(R)-9-[2-(stearoyloxymethyl)-4-(L-valyloxy) butyl]guanine;OCTADECANOIC ACID, (2R)-2-((2-AMINO-1,6-DIHYDRO-6-OXO-9H-PURIN-9-YL)METHYL)-4-((2S)-2-AMINO-3-METHYL-1-OXOBUTOXY)BUTYL ESTER; |
| IUPAC Name | [(2R)-4-[(2S)-2-amino-3-methylbutanoyl]oxy-2-[(2-amino-6-oxo-1H-purin-9-yl)methyl]butyl] octadecanoate |
| Molecular Weight | 618.85 |
| Molecular Formula | C33H58N6O5 |
| Canonical SMILES | CCCCCCCCCCCCCCCCCC(OC[C@@H](CN1C=NC2=C1NC(N)=NC2=O)CCOC([C@@H](N)C(C)C)=O)=O |
| InChI | InChI=1S/C33H58N6O5/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-27(40)44-23-26(20-21-43-32(42)28(34)25(2)3)22-39-24-36-29-30(39)37-33(35)38-31(29)41/h24-26,28H,4-23,34H2,1-3H3,(H3,35,37,38,41)/t26-,28+/m1/s1 |
| InChIKey | ACBSZTQIFTYFGH-IAPPQJPRSA-N |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Description of First Aid Measures
Eye contact
Remove any contact lenses, locate eye-wash station, and flush eyes immediately with large amounts of water. Separate eyelids with fingers to ensure adequate flushing. Promptly call a physician.
Skin contactRinse skin thoroughly with large amounts of water. Remove contaminated clothing and shoes and call a physician.
InhalationImmediately relocate self or casualty to fresh air. If breathing is difficult, give cardiopulmonary resuscitation (CPR). Avoid mouth-to-mouth resuscitation.
IngestionWash out mouth with water; Do NOT induce vomiting; call a physician.